Gottfried Konecny, MD
Hematology & Oncology · Los Angeles, CANPI 1427190115
Payments from drug & device makers
Across 644 payments — averaging $11,820 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$2.5M
- Tesaro, Inc.$2.1M
- GSK$959K
- Genmab U.S., Inc.$638K
- AbbVie$423K
- AstraZeneca$289K
- plus $694K from 14 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 110 | $2,533,902 |
| Tesaro, Inc. | 81 | $2,075,066 |
| GSK | 143 | $959,464 |
| Genmab U.S., Inc. | 19 | $638,260 |
| AbbVie | 99 | $423,143 |
| AstraZeneca | 77 | $288,849 |
| Clovis Oncology, Inc. | 47 | $204,902 |
| Lilly USA, LLC | 1 | $175,240 |
| Immunogen, Inc. | 39 | $93,094 |
| Acerta Pharma LLC | 3 | $50,265 |
| Gilead(2 entities) | 9 | $41,133 |
| Trillium Therapeutics USA, LLC | 1 | $40,539 |
| Array Biopharma Inc | 4 | $33,301 |
| Astrazeneca UK Limited | 1 | $27,235 |
| Amgen | 2 | $13,864 |
| Foundation Medicine, Inc. | 1 | $11,625 |
| Myriad Genetic Laboratories, Inc. | 3 | $2,373 |
| Daiichi Sankyo Inc. | 2 | $70 |
| Sanofi | 1 | $25 |
| Stemline Therapeutics Inc. | 1 | $18 |
How this compares
$7,612,366 in reported general payments places this provider in the 95th percentile of 1,363 hematology & oncology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other hematology & oncology in Los Angeles
- David BerzLos Angeles$43.3M
- Nicholas McAndrewLos Angeles$22.9M
- Antoni RibasLos Angeles$13M
- Gary SchillerLos Angeles$11.9M
- Matthew RettigLos Angeles$8.2M
- Lasika SeneviratneLos Angeles$8.1M
- Gary BuchschacherLos Angeles$7.9M
- Edward GaronLos Angeles$7.9M
- Sven de VosLos Angeles$6.7M
- Jorge NievaLos Angeles$6.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.